These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28883001)

  • 101. miR-142-3p attenuates breast cancer stem cell characteristics and decreases radioresistance in vitro.
    Troschel FM; Böhly N; Borrmann K; Braun T; Schwickert A; Kiesel L; Eich HT; Götte M; Greve B
    Tumour Biol; 2018 Aug; 40(8):1010428318791887. PubMed ID: 30091683
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity.
    Strietz J; Stepputtis SS; Follo M; Bronsert P; Stickeler E; Maurer J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670400
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress.
    Zhang W; Liu W; Jia L; Chen D; Chang I; Lake M; Bentolila LA; Wang CY
    Mol Cell; 2021 May; 81(10):2148-2165.e9. PubMed ID: 33743195
    [TBL] [Abstract][Full Text] [Related]  

  • 104. KDM4B-regulated unfolded protein response as a therapeutic vulnerability in
    Wang W; Oguz G; Lee PL; Bao Y; Wang P; Terp MG; Ditzel HJ; Yu Q
    J Exp Med; 2018 Nov; 215(11):2833-2849. PubMed ID: 30266800
    [No Abstract]   [Full Text] [Related]  

  • 105. KDM4A regulates the maternal-to-zygotic transition by protecting broad H3K4me3 domains from H3K9me3 invasion in oocytes.
    Sankar A; Lerdrup M; Manaf A; Johansen JV; Gonzalez JM; Borup R; Blanshard R; Klungland A; Hansen K; Andersen CY; Dahl JA; Helin K; Hoffmann ER
    Nat Cell Biol; 2020 Apr; 22(4):380-388. PubMed ID: 32231309
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Targeting USP1-dependent KDM4A protein stability as a potential prostate cancer therapy.
    Cui SZ; Lei ZY; Guan TP; Fan LL; Li YQ; Geng XY; Fu DX; Jiang HW; Xu SH
    Cancer Sci; 2020 May; 111(5):1567-1581. PubMed ID: 32133742
    [TBL] [Abstract][Full Text] [Related]  

  • 107. KDM4 Orchestrates Epigenomic Remodeling of Senescent Cells and Potentiates the Senescence-Associated Secretory Phenotype.
    Zhang B; Long Q; Wu S; Xu Q; Song S; Han L; Qian M; Ren X; Liu H; Jiang J; Guo J; Zhang X; Chang X; Fu Q; Lam EW; Campisi J; Kirkland JL; Sun Y
    Nat Aging; 2021 May; 1(5):454-472. PubMed ID: 34263179
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1.
    Xiang Y; Yan K; Zheng Q; Ke H; Cheng J; Xiong W; Shi X; Wei L; Zhao M; Yang F; Wang P; Lu X; Fu L; Lu X; Li F
    Cancer Res; 2019 Jan; 79(1):86-98. PubMed ID: 30459150
    [TBL] [Abstract][Full Text] [Related]  

  • 109. A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival.
    Massett ME; Monaghan L; Patterson S; Mannion N; Bunschoten RP; Hoose A; Marmiroli S; Liskamp RMJ; Jørgensen HG; Vetrie D; Michie AM; Huang X
    Cell Death Dis; 2021 Jun; 12(6):573. PubMed ID: 34083515
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Breast Cancer Stem Cells Upregulate IRF6 in Stromal Fibroblasts to Induce Stromagenesis.
    Muralidharan H; Hansen T; Steinle A; Schumacher D; Stickeler E; Maurer J
    Cells; 2024 Aug; 13(17):. PubMed ID: 39273037
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Iron metabolism: backfire of cancer cell stemness and therapeutic modalities.
    Yu R; Hang Y; Tsai HI; Wang D; Zhu H
    Cancer Cell Int; 2024 May; 24(1):157. PubMed ID: 38704599
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma.
    Abu-Zaid A; Fang J; Jin H; Singh S; Pichavaram P; Wu Q; Tillman H; Janke L; Rosikiewicz W; Xu B; Van De Velde LA; Guo Y; Li Y; Shendy NAM; Delahunty IM; Rankovic Z; Chen T; Chen X; Freeman KW; Hatley ME; Durbin AD; Murray PJ; Murphy AJ; Thomas PG; Davidoff AM; Yang J
    Cell Rep Med; 2024 Mar; 5(3):101468. PubMed ID: 38508144
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2-Hydroxyglutarate.
    Belle R; Saraç H; Salah E; Bhushan B; Szykowska A; Roper G; Tumber A; Kriaucionis S; Burgess-Brown N; Schofield CJ; Brown T; Kawamura A
    J Med Chem; 2024 Mar; 67(6):4525-4540. PubMed ID: 38294854
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Oncogenic Cells of Renal Embryonic Lineage Sensitive to the Small-Molecule Inhibitor QC6352 Display Depletion of KDM4 Levels and Disruption of Ribosome Biogenesis.
    Pichavaram P; Jablonowski CM; Fang J; Fleming AM; Gil HJ; Boghossian AS; Rees MG; Ronan MM; Roth JA; Morton CL; Zambetti GP; Davidoff AM; Yang J; Murphy AJ
    Mol Cancer Ther; 2024 Apr; 23(4):478-491. PubMed ID: 37988559
    [TBL] [Abstract][Full Text] [Related]  

  • 115. KDM4C-mediated senescence defense is a targetable vulnerability in gastric cancer harboring TP53 mutations.
    Wang K; Gong Z; Chen Y; Zhang M; Wang S; Yao S; Liu Z; Huang Z; Fei B
    Clin Epigenetics; 2023 Oct; 15(1):163. PubMed ID: 37848946
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Carcinogenesis promotion in oral squamous cell carcinoma: KDM4A complex-mediated gene transcriptional suppression by LEF1.
    Hou Y; Yu W; Wu G; Wang Z; Leng S; Dong M; Li N; Chen L
    Cell Death Dis; 2023 Aug; 14(8):510. PubMed ID: 37553362
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Breast Cancer Stem Cell-Derived Tumors Escape from γδ T-cell Immunosurveillance In Vivo by Modulating γδ T-cell Ligands.
    Raute K; Strietz J; Parigiani MA; Andrieux G; Thomas OS; Kistner KM; Zintchenko M; Aichele P; Hofmann M; Zhou H; Weber W; Boerries M; Swamy M; Maurer J; Minguet S
    Cancer Immunol Res; 2023 Jun; 11(6):810-829. PubMed ID: 37139603
    [TBL] [Abstract][Full Text] [Related]  

  • 118. TACH101, a first-in-class pan-inhibitor of KDM4 histone demethylase.
    Chandhasin C; Dang V; Perabo F; Del Rosario J; Chen YK; Filvaroff E; Stafford JA; Clarke M
    Anticancer Drugs; 2023 Nov; 34(10):1122-1131. PubMed ID: 37067993
    [TBL] [Abstract][Full Text] [Related]  

  • 119. The Potential of PSMA as a Vascular Target in TNBC.
    Heesch A; Ortmanns L; Maurer J; Stickeler E; Sahnoun SEM; Mottaghy FM; Morgenroth A
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831218
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Targeting epigenetic regulators to overcome drug resistance in cancers.
    Wang N; Ma T; Yu B
    Signal Transduct Target Ther; 2023 Feb; 8(1):69. PubMed ID: 36797239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.